Public limited company · Gent · incorporated on 19/01/2007
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 1,3 M € | -23.7% | 1,6 M € | +14.2% | 1,4 M € | +5.6% | 1,4 M € | +88.0% | 724,4 k € | — | — | — | 7,2 M € | +2.9% | 7,0 M € | -0.9% | 7,1 M € | +13.3% | 6,2 M € | +0.7% | 6,2 M € | +14.6% | 5,4 M € | +37.2% | 3,9 M € | +29.7% | 3,0 M € | +98.7% | 1,5 M € | +28.6% | 1,2 M € | ||||||
| Gross margin | 296,2 k € | +118115.1% | -251,0 € | -100.8% | 33,0 k € | — | — | — | 183,8 k € | -63.8% | 507,5 k € | -41.4% | 865,6 k € | — | — | — | — | — | — | — | — | — | — | |||||||||||||||
| EBITDA | 212,3 k € | +738.3% | -33,3 k € | -227.5% | -10,2 k € | -94.4% | -5,2 k € | -105.2% | 100,2 k € | -64.8% | 284,9 k € | +702.6% | 35,5 k € | +121.1% | -168,2 k € | -200.5% | 167,3 k € | +999.1% | -18,6 k € | -111.6% | 160,9 k € | -67.9% | 500,6 k € | +144.9% | 204,4 k € | -32.9% | 304,9 k € | +40.3% | 217,3 k € | +349.4% | 48,4 k € | -65.8% | 141,3 k € | +322.6% | -63,5 k € | -371.1% | 23,4 k € | |
| Operating profit | 162,0 k € | +52.4% | 106,3 k € | +139.2% | 44,4 k € | +97.5% | 22,5 k € | -65.0% | 64,2 k € | -64.0% | 178,5 k € | +3712.5% | 4,7 k € | +102.1% | -222,4 k € | -912.4% | 27,4 k € | +110.0% | -274,5 k € | -855.3% | 36,3 k € | -89.9% | 361,1 k € | +575.9% | 53,4 k € | -67.8% | 165,7 k € | +14.8% | 144,4 k € | +3985.7% | 3,5 k € | -96.7% | 108,3 k € | +213.2% | -95,6 k € | -2353.8% | -3,9 k € | |
| Profit/loss | 120,6 k € | +43.6% | 84,0 k € | +120.7% | 38,1 k € | +71.6% | 22,2 k € | -65.4% | 64,1 k € | -64.0% | 178,1 k € | +10482.1% | -1,7 k € | +99.3% | -238,4 k € | -1324.0% | 19,5 k € | +106.6% | -294,2 k € | -2941.5% | -9,7 k € | -104.4% | 218,3 k € | +1026.3% | 19,4 k € | -78.6% | 90,4 k € | +4.2% | 86,7 k € | +2339.3% | 3,6 k € | -96.6% | 104,4 k € | +209.9% | -95,0 k € | -1513.7% | -5,9 k € | |
| Equity | 779,5 k € | +18.3% | 658,8 k € | +14.6% | 574,8 k € | +7.1% | 536,8 k € | +4.3% | 514,6 k € | +14.2% | 450,6 k € | +65.4% | 272,4 k € | -0.6% | 274,2 k € | -46.5% | 512,6 k € | +4.0% | 493,1 k € | -37.4% | 787,3 k € | -1.2% | 797,0 k € | +37.7% | 578,7 k € | +3.5% | 559,3 k € | +19.3% | 468,8 k € | +22.7% | 382,1 k € | +0.9% | 378,5 k € | +38.1% | 274,1 k € | -25.7% | 369,1 k € | |
| Total assets | 1,1 M € | +21.6% | 923,3 k € | +7.4% | 859,7 k € | -20.6% | 1,1 M € | -34.7% | 1,7 M € | +69.3% | 979,8 k € | +72.1% | 569,3 k € | -73.1% | 2,1 M € | -8.0% | 2,3 M € | -16.9% | 2,8 M € | -15.0% | 3,3 M € | +7.3% | 3,0 M € | +30.4% | 2,3 M € | -13.0% | 2,7 M € | +17.8% | 2,3 M € | +6.1% | 2,1 M € | +35.3% | 1,6 M € | +72.3% | 918,4 k € | -2.2% | 939,4 k € | |
| Cash | 756,0 € | -77.2% | 3,3 k € | -1.6% | 3,4 k € | -96.4% | 94,2 k € | -91.2% | 1,1 M € | +392.9% | 217,2 k € | +179.3% | 77,8 k € | -87.7% | 632,7 k € | -0.7% | 636,9 k € | +0.9% | 631,4 k € | +65.8% | 380,7 k € | -8.4% | 415,5 k € | +63.7% | 253,9 k € | -54.4% | 556,8 k € | -2.1% | 568,8 k € | -1.0% | 574,4 k € | +47.8% | 388,7 k € | +146.2% | 157,9 k € | -22.3% | 203,2 k € | |
| Debts | 343,3 k € | +33.0% | 258,1 k € | -8.5% | 282,1 k € | -48.4% | 546,4 k € | -52.2% | 1,1 M € | +116.1% | 529,3 k € | +78.3% | 296,9 k € | -83.4% | 1,8 M € | +3.2% | 1,7 M € | -23.7% | 2,3 M € | -8.1% | 2,5 M € | +10.3% | 2,2 M € | +28.0% | 1,7 M € | -17.3% | 2,1 M € | +17.5% | 1,8 M € | +4.6% | 1,7 M € | +43.0% | 1,2 M € | +86.8% | 644,3 k € | +13.0% | 570,3 k € | |
| Staff | — | 0 | — | — | — | — | 2,3 | 10,7 | 10,7 | 14,2 | 14,5 | 13,4 | 14,4 | 13,7 | 12 | 9 | 6 | 5,3 | 2 | |||||||||||||||||||
Public limited company profitable and well capitalised. Cash position declining (-77.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
2PHARMA is a Public limited company incorporated in 2007. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette